ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,663,000 | -30.7% | 475,000 | 0.0% | 0.08% | -32.4% |
Q3 2017 | $2,399,000 | +48.5% | 475,000 | 0.0% | 0.11% | +35.4% |
Q2 2017 | $1,615,000 | -2.9% | 475,000 | 0.0% | 0.08% | -14.6% |
Q1 2017 | $1,663,000 | +62.9% | 475,000 | 0.0% | 0.10% | +41.2% |
Q4 2016 | $1,021,000 | -26.0% | 475,000 | +9.6% | 0.07% | -20.9% |
Q3 2016 | $1,379,000 | +14.4% | 433,500 | 0.0% | 0.09% | -3.4% |
Q2 2016 | $1,205,000 | -29.4% | 433,500 | +0.0% | 0.09% | -37.8% |
Q1 2016 | $1,708,000 | -58.1% | 433,496 | +4.4% | 0.14% | -53.7% |
Q4 2015 | $4,081,000 | +2.3% | 415,196 | +6.7% | 0.31% | -4.6% |
Q3 2015 | $3,991,000 | -47.2% | 388,996 | -4.8% | 0.32% | -41.3% |
Q2 2015 | $7,565,000 | – | 408,496 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $6,398,000 | 5.64% |
EcoR1 Capital, LLC | 3,917,972 | $13,713,000 | 1.54% |
Redmile Group, LLC | 1,886,792 | $6,604,000 | 0.29% |
Rock Springs Capital Management LP | 475,000 | $1,663,000 | 0.08% |
VIKING GLOBAL INVESTORS LP | 1,384,300 | $4,845,000 | 0.03% |
Artal Group S.A. | 500,000 | $1,750,000 | 0.03% |
Alyeska Investment Group, L.P. | 704,524 | $2,466,000 | 0.02% |
Glen Harbor Capital Management LLC | 153,238 | $536,000 | 0.01% |
RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $279,000 | 0.01% |
Meadow Creek Investment Management LLC | 126,196 | $442,000 | 0.01% |